These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 9475275

  • 21. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.
    Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M.
    J Hypertens; 1998 Mar; 16(3):385-93. PubMed ID: 9557932
    [Abstract] [Full Text] [Related]

  • 22. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
    Cervenka L, Wang CT, Mitchell KD, Navar LG.
    Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of selective A1 receptor blockade on glomerular hemodynamics: involvement of renin-angiotensin system.
    Munger KA, Jackson EK.
    Am J Physiol; 1994 Nov; 267(5 Pt 2):F783-90. PubMed ID: 7977781
    [Abstract] [Full Text] [Related]

  • 31. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
    Perico N, Remuzzi A, Sangalli F, Azzollini N, Mister M, Ruggenenti P, Remuzzi G.
    J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785
    [Abstract] [Full Text] [Related]

  • 32. Candesartan cilexetil and renal hemodynamics in hypertensive patients.
    Fridman K, Wysocki M, Friberg P, Andersson OK.
    Am J Hypertens; 2000 Sep; 13(9):1045-8. PubMed ID: 10981559
    [Abstract] [Full Text] [Related]

  • 33. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
    Plum J, Bünten B, Németh R, Grabensee B.
    J Am Soc Nephrol; 1998 Dec; 9(12):2223-34. PubMed ID: 9848776
    [Abstract] [Full Text] [Related]

  • 34. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
    Ruilope L.
    J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of an angiotensin II receptor antagonist in managing hyperaldosteronism.
    Stokes GS, Monaghan JC, Ryan M, Woodward M.
    J Hypertens; 2001 Jun; 19(6):1161-5. PubMed ID: 11403366
    [Abstract] [Full Text] [Related]

  • 36. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
    Preckel B, Schlack W, Gonzàlez M, Obal D, Barthel H, Thämer V.
    Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
    [Abstract] [Full Text] [Related]

  • 37. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.
    Munafo A, Christen Y, Nussberger J, Shum LY, Borland RM, Lee RJ, Waeber B, Biollaz J, Brunner HR.
    Clin Pharmacol Ther; 1992 May; 51(5):513-21. PubMed ID: 1587065
    [Abstract] [Full Text] [Related]

  • 38. Impact of gender on the renal response to angiotensin II.
    Miller JA, Anacta LA, Cattran DC.
    Kidney Int; 1999 Jan; 55(1):278-85. PubMed ID: 9893137
    [Abstract] [Full Text] [Related]

  • 39. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
    Kopkan L, Kramer HJ, Husková Z, Vanourková Z, Bäcker A, Bader M, Ganten D, Cervenka L.
    J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925
    [Abstract] [Full Text] [Related]

  • 40. AT1-receptor antagonists abolish glomerular MCP-1 expression in a model of mesangial proliferative glomerulonephritis.
    Wolf G, Schneider A, Helmchen U, Stahl RA.
    Exp Nephrol; 1998 Apr; 6(2):112-20. PubMed ID: 9567217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.